Patrick Warnat

Automatic identification of subcellular phenotypes on human cell arrays.

C. Conrad, H. Erfle, Patrick Warnat, 2004, Genome research.

Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

Patrick Warnat, R. Eils, S. Haas, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Arrays Automatic Identification of Subcellular Phenotypes on Human Cell data

C. Conrad, H. Erfle, Patrick Warnat, 2004 .

Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.

Roland Eils, Barbara Hero, Frank Berthold, 2007, Cancer letters.

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling

Roland Eils, Benedikt Brors, Holger Christiansen, 2004, Oncogene.

Prognostic impact of gene expression-based classification for neuroblastoma.

Roland Eils, Lars Kaderali, Gudrun Schleiermacher, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.

Roland Eils, Axel Benner, Benedikt Brors, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes

Roland Eils, Benedikt Brors, Patrick Warnat, 2005, BMC Bioinformatics.

Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome

Barbara Hero, Frank Berthold, Benedikt Brors, 2006, Clinical Cancer Research.

Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes

Roland Eils, Benedikt Brors, Matthias Fischer, 2007, BMC Cancer.